Kenacort-A Orabase
Kenacort-A Orabase is a medicine authorised by Swissmedic under authorisation number 35039. The authorisation holder is Dermapharm AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 April 1970 and the authorisation is valid without a time limit. ATC code A01AC01 places the medicine in the group Stomatological preparations.
| Authorisation number | 35039 |
|---|---|
| Name | Kenacort-A Orabase |
| Full name | Kenacort-A Orabase, Paste zur Anwendung in der Mundhöhle |
| Authorisation holder | Dermapharm AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A01AC01 |
| First authorisation | 16 April 1970 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Kenacort-A Orabase, Paste zur Anwendung in der Mundhöhle | B | 16 April 1970 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 15 | 5 | g | A01AC01 | 12.03.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Kenacort-A Orabase authorised in Switzerland?
Yes. Kenacort-A Orabase is authorised by Swissmedic under authorisation number 35039, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Kenacort-A Orabase have?
Kenacort-A Orabase is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Kenacort-A Orabase?
The authorisation holder is Dermapharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.